MX9709980A - Ciertos derivados de bencilamina sustituidos: una nueva clase de ligandos especificos del neuropeptido y1. - Google Patents

Ciertos derivados de bencilamina sustituidos: una nueva clase de ligandos especificos del neuropeptido y1.

Info

Publication number
MX9709980A
MX9709980A MX9709980A MX9709980A MX9709980A MX 9709980 A MX9709980 A MX 9709980A MX 9709980 A MX9709980 A MX 9709980A MX 9709980 A MX9709980 A MX 9709980A MX 9709980 A MX9709980 A MX 9709980A
Authority
MX
Mexico
Prior art keywords
neuropeptide
new class
specific ligands
certain substituted
substituted benzylamine
Prior art date
Application number
MX9709980A
Other languages
English (en)
Other versions
MXPA97009980A (es
Inventor
John M Peterson
Charles M Blum
Guolin Cai
Alan Hutchison
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1995/014472 external-priority patent/WO1996014307A1/en
Application filed by Pfizer filed Critical Pfizer
Publication of MX9709980A publication Critical patent/MX9709980A/es
Publication of MXPA97009980A publication Critical patent/MXPA97009980A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invencion comprende compuestos de la formula I y las sales farmacéuticamente aceptables del mismo en donde Ar es un grupo arilo preferiblemente seleccionado del grupo que consiste de fenilo, 2-, 3-, o 4-piridilo, 2- o 3-tienilo, 2-, 4- o 5-pirimidilo, cada uno de los cuales es opcionalmente mono o disubstituido con halogeno, hidroxilo, alcoxi inferior o alquilo inferior; B es azufre, oxígeno, N(R5) o C(R5)(R6); o B representa un grupo de la formula II opcionalmente substituido con halogeno, hidroxilo, alquilo inferior o alcoxi inferior; n es 1, 2 o 3, m es 2, 3 o 4, W, X, Y y T son los mismos o diferentes y representan hidrogeno, halogeno, hidroxilo, alcoxi inferior o alcoxi alcoxi inferior; R1 y R2 son los mismos o diferentes y representan hidrogeno alquilo inferior; R3 y R4 son los mismos o diferentes y representan hidrogeno, alquilo inferior, o alcoxi inferior; R5 representa alquilo inferior, fenilo, 2, 3 o 4-piridilo, fenilo, alquilo inferior o 2, 3 o 4-piridilo, alquilo inferior; y A y R6 son los mismos o diferentes y representan hidrogeno, hidroxilo, amino, alquilo inferior, alcoxi inferior, fenilo, benciloxi opcionalmente substituido, 2, 3 o 4 piridilo, fenoxi, 2, 3 o 4 piridiloxi, o (CH2)p-A'-(CH2)q-B' en donde p es 0-5, q es 1-5 y A' es un enlace directo, oxígeno o azufre, y B' es hidrogeno, alquilo inferior, alcoxi inferior, fenilo, 2, 3 o 4 piridilo, fenoxi, 2, 3 o 4 piridiloxi, carboxilo, crboalcoxi, carboxamido, mono o dialquilcarboxamido, amino o mono- o dialquilamino.
MXPA/A/1997/009980A 1995-06-07 1997-12-08 Ciertos derivados de bencilamina sustituidos:unanueva clase de ligandos especificos del neuropeptido y1 MXPA97009980A (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US47838395A 1995-06-07 1995-06-07
US48497495A 1995-06-07 1995-06-07
US484974 1995-06-07
PCT/US1995/014472 WO1996014307A1 (en) 1994-11-07 1995-11-07 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
PCPCT/US1995/014472 1995-11-07
USUS95/14472 1995-11-07
PCT/US1996/005843 WO1996040660A1 (en) 1995-06-07 1996-04-26 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands
US478383 2000-01-06

Publications (2)

Publication Number Publication Date
MX9709980A true MX9709980A (es) 1998-03-29
MXPA97009980A MXPA97009980A (es) 1998-10-15

Family

ID=

Also Published As

Publication number Publication date
BR9609334A (pt) 1999-05-25
IL117997A0 (en) 1996-10-31
JPH10507203A (ja) 1998-07-14
PE34297A1 (es) 1997-09-24
MA23860A1 (fr) 1996-12-31
EP0833823A1 (en) 1998-04-08
CA2220958A1 (en) 1996-12-19
WO1996040660A1 (en) 1996-12-19
TR199600382A2 (tr) 1996-12-21
CO4700426A1 (es) 1998-12-29
AU5578796A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
DK0915859T3 (da) Visse substituerede benzylaminderivater; en ny klasse af Neuropeptid Y1-specifikke ligander
NO972091L (no) Bestemte substituerte benzylaminderivater; en ny klasse nouropeptid-yl-spesifikke ligander
HUP0202636A2 (hu) Alkilén-diamin-csoporttal helyettesített heterogyűrűs vegyületek és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
IS6275A (is) Heteróhringa efnasambönd og notkun þeirra sem mótlyf efnaskiptaglútamatviðtaka
AU6073596A (en) Intermediates useful in the preparation of 5-HT4 receptor antagonists
TW226375B (es)
DE69820632D1 (de) 2-phenyl-substituierte 1-(n-phenylaminoalkyl)-piperazin-derivate
UA66864C2 (uk) Похідні сечовини, фармацевтична композиція і спосіб лікування або профілактики запальних, аутоімунних або респіраторних захворювань
BG104853A (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
MY110142A (en) Thiazolidinedione derivatives, their production and use
JO2321B1 (en) 4-phenyl-pyridine derivatives
ATE199253T1 (de) Antidepressiv wirkende 3-halophenylpiperazinyl- propylderivate von substituierten triazolonen und triazoldionen
DE69202120D1 (de) Harnstoffderivate, ihre Herstellung und ihre Verwendung bei der Therapie.
HU9201887D0 (en) Process for the production of //aralkyl-piperidine-4-yl/-methyl/-2a,3,4,5-tetrahydro-1-/2h/-acenaphtylene-1-on derivatives and of medical preparations containing them as active agents
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
WO2000071520A3 (en) Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors
MX9709980A (es) Ciertos derivados de bencilamina sustituidos: una nueva clase de ligandos especificos del neuropeptido y1.
UA89807C2 (ru) Производные 3-фенилпропионовой кислоты для лечения диабета
DK0894787T3 (da) 3,4-disubstituerede phenylethanolaminolaminotetralincarboxylsyre-derivater
AU4720389A (en) N-pyridinyl-9h-carbazol-9-amines, a process their preparation and their use as medicaments
YU3099A (sh) Novi derivati eritromicina, postupak za njihovo dobijanje i njihova primena
DE69810340D1 (de) Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems
DE60224509D1 (de) Imidazolderivate verwendbar als histamin h3 rezeptorliganden
ES537805A0 (es) Un derivado de acetileno
NZ508535A (en) 17-Halogenated 19-nor steroid derivatives useful for treating or preventing osteoporosis, cardiovascular disorders, menopause or perimenopause